Crescel is sharing an important research update: A new clinical study signals a meaningful shift in how rosacea is managed.
The results are striking:
- 54% reduction in redness vs. 23% for standard treatment
- 74% reduction in inflammatory lesions vs. just 17% (not statistically significant)
- No negative side effects observed
Read the full release below:
Press Release from PR Newswire www.prnewswire.com